| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 2.31× | 2.31× | 1.46× | 3.37× | 6.01× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 5.37× | 7.67× | 79.82× | 16.22× | −12.56× | ||
| 1.06× | 1.06× | 1.00× | 0.83× | 0.83× | ||
| 1.23× | 1.23× | 1.37× | 1.72× | 1.44× | ||
| 0.77× | 0.77× | 0.81× | 0.98× | 0.91× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 6.01 | 3.37 | 1.46 | 2.31 | 2.31 | |
| Working Capital Turnover | -12.56 | 16.22 | 79.82 | 7.67 | 5.37 | |
| Asset Turnover | 0.83 | 0.83 | 1.00 | 1.06 | 1.06 | |
| Cash Conversion (CFO/Net Income) | 1.44 | 1.72 | 1.37 | 1.23 | 1.23 | |
| CFO/EBITDA | 0.91 | 0.98 | 0.81 | 0.77 | 0.77 |